| 1 | Board of Directors' oral report on the Company's activities in the past financial year | Non-Voting |
| 2 | Receive the Annual Report | Abstain |
| 3.1 | Receive Remuneration Report 2019 | Non-Voting |
| 3.2a | Approve Fees Paid to the Board of Directors in 2019 | For |
| 3.2b | Approve Fees Payable to the Board of Directors in 2020 | For |
| 3.3 | Approve Remuneration Policy | Oppose |
| 3.4 | Amend Articles Re: Voting on the Company's Remuneration Report at Annual General Meetings | For |
| 4 | Approve the Dividend | For |
| 5.1 | Reelect Helge Lund as Director and Chair | Abstain |
| 5.2 | Reelect Jeppe Christiansen as Director and Deputy Chair | Abstain |
| 5.3a | Reelect Brian Daniels as Director | For |
| 5.3b | Reelect Laurence Debroux as Director | For |
| 5.3c | Reelect Andreas Fibig as Director | For |
| 5.3d | Reelect Sylvie Gregoire as Director | For |
| 5.3e | Reelect Liz Hewitt as Director | For |
| 5.3f | Reelect Kasim Kutay as Director | For |
| 5.3g | Reelect Martin Mackay as Director | For |
| 6 | Ratify PricewaterhouseCoopers as Auditors | Abstain |
| 7.1 | Reduce Share Capital | Oppose |
| 7.2 | Authorise Share Repurchase | Oppose |
| 7.3a | Approve Creation of Pool of Capital for the Benefit of Employees | For |
| 7.3b | Issue Shares with Pre-emption Rights | For |
| 7.3c | Approve Creation of Pool of Capital without Preemptive Rights | For |
| 7.4 | Approve Donation to the World Diabetes Foundation | For |
| 8 | Shareholder Proposal: Disclosure of the Ratio between Executive and Employee Remuneration in the Annual Reports | Oppose |
| 9 | Transact Any Other Business | Oppose |
